Skip to main content
Clinical Trials/CTRI/2016/10/007412
CTRI/2016/10/007412
Recruiting
Phase 4

To Compare Efficacy and Safety of Levetiracetam with Phenobarbitone in Neonates with Perinatal Asphyxia: A Randomized Controlled Trial - LeveNeo Trial

Sarojini Naidu Children Hospital0 sites60 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Sarojini Naidu Children Hospital
Enrollment
60
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Sarojini Naidu Children Hospital

Eligibility Criteria

Inclusion Criteria

  • Full term neonates (37 completed weeks to less than 42 weeks of gestational age)
  • Less than 24 hours of age at presentation
  • HIE stage II or III (as per Sarnat and Sarnat staging)

Exclusion Criteria

  • Neonates received at least one dose of anticonvulsants
  • Severe congenital anomalies or CNS malformations
  • Convulsions due to hypoglycemia/hypocalcemia
  • Neonatal Sepsis
  • Major intracranial hemorrhage
  • Serum creatinine more than 0\.8 mg/dl

Outcomes

Primary Outcomes

Not specified

Similar Trials